focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,781.00
Bid: 1,780.50
Ask: 1,781.00
Change: -31.50 (-1.74%)
Spread: 0.50 (0.028%)
Open: 1,792.50
High: 1,802.00
Low: 1,781.00
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Stocks dip despite barrage of positive readings on the economy

Fri, 23rd Apr 2021 12:04

(Sharecast News) - Stocks are holding lower at the end of the week despite very positive news out on the UK economy, after Bloomberg reported that Democrats on Capitol Hill want to double the US capital gains tax to nearly 39.6%.
"European markets are on the back foot in early trade, with valuations taking a dive in the wake of Joe Biden's proposal to implement a near 50% stamp duty rate on high earners. With the past year having seen traders react with glee over repeated bouts of stimulus, traders are gradually seeing the uncomfortable truth that those debts have to be paid one way or another," said Josh Mahony, senior market analyst at IG.

"Quite whether Biden manages to garner enough support to pass this bill remains to be seen, with the president likely to require almost unanimous support from the Democrats given the expected widespread rejection from the GOP."

Another key consideration according to experts was whether any tax hikes would be applied retroactively to 2021.

Against that backdrop, as of 1205 BST the FTSE 100 was trading lower by 0.48% or 33.12 points to 6,905.04, while the second-tier index was down by 0.22% or 49.39 points at 22,315.48.

Futures tracking the S&P 500 on the other hand were now bouncing back by 11.5 points to 4,139.25.

Sterling was higher alongside too, adding 0.33% to 1.3885.

Barrage of positive economic data

The news on the economic front nevertheless was surprisingly positive.

According to the Office for National Statistics, UK retail sales surged at a month-on-month pace of 5.4% in March (consensus: 1.5%).

That was despite non-essential stores having remained shut until 12 April.

IHS Markit's Purchasing Managers Indices for factory and services also came in ahead of forecasts for April, with record levels of optimism for the year ahead "setting the scene for a bumper second quarter for the economy".

Consultancy GfK meanwhile reported an improvement in its UK consumer confidence index from -16 for March to -15 in April, although shoppers appeared to be returning "quite tentatively" to stores, said Samuel Tombs at Pantheon Macroeconomics.

Public sector net borrowing data for March also came in better than expected, at £28.0bn (consensus: £22.0bn), for total 2020/21 fiscal year borrowing £303.1bn or 14.5% of GDP, the most since WWII, but in any case than the OBR's projection for £354.6bn in the March budget.

First Group sells US assets to lower debt pile

FirstGroup has agreed to sell its First Student and First Transit US bus businesses to EQT Infrastructure for an enterprise value of £3.3bn. The UK transport group said it would use £2.19bn of initial net proceeds to cut debt, pay into its pension schemes and return £365m, or 30p a share, to shareholders during 2021.

GlaxoSmithKline said the US Food and Drug Administration (FDA) has approved 'Jemperli', or dostarlimab-gxly, based on its Biologics License Application. The AIM-traded firm said dostarlimab, a programmed death receptor-1 (PD-1) blocking antibody, is indicated for the treatment of adult patients with mismatch repair-deficient recurrent or advanced endometrial cancer, as determined by an FDA-approved test, that have progressed on or following prior treatment with a platinum-containing regimen. It said the indication was given accelerated approval based on tumour response rate and durability of response.

LondonMetric Property has sold two long income assets let to Marks & Spencer and Wickes in Derby for a combined £11.1m to unnamed buyers. The sale represents a blended net initial yield of 6% and a 7% surplus to the last reported book value. One property is a M&S Foodhall, sold by way of a forward commitment to an overseas private investor for £6.2m and the other a Wickes store, sold to an overseas property company for £4.9m.

Market Movers

FTSE 100 (UKX) 6,908.47 -0.43%
FTSE 250 (MCX) 22,309.18 -0.25%
techMARK (TASX) 4,346.48 -0.39%

FTSE 100 - Risers

Intertek Group (ITRK) 6,252.00p 1.86%
Taylor Wimpey (TW.) 187.55p 1.49%
Evraz (EVR) 639.40p 1.46%
Just Eat Takeaway.Com N.V. (CDI) (JET) 7,956.00p 1.26%
Glencore (GLEN) 295.90p 1.16%
Flutter Entertainment (CDI) (FLTR) 15,075.00p 1.14%
Smith (DS) (SMDS) 417.10p 0.97%
Anglo American (AAL) 3,119.50p 0.82%
InterContinental Hotels Group (IHG) 5,148.00p 0.82%
WPP (WPP) 960.00p 0.80%

FTSE 100 - Fallers

International Consolidated Airlines Group SA (CDI) (IAG) 196.08p -2.20%
Next (NXT) 7,880.00p -2.11%
Hargreaves Lansdown (HL.) 1,667.50p -1.74%
Diageo (DGE) 3,260.00p -1.70%
Hikma Pharmaceuticals (HIK) 2,396.00p -1.68%
Reckitt Benckiser Group (RKT) 6,691.00p -1.62%
Smith & Nephew (SN.) 1,470.00p -1.47%
United Utilities Group (UU.) 953.40p -1.47%
Sainsbury (J) (SBRY) 245.30p -1.37%
Auto Trader Group (AUTO) 569.00p -1.35%

FTSE 250 - Risers

FirstGroup (FGP) 92.55p 8.75%
SSP Group (SSPG) 337.90p 2.83%
Network International Holdings (NETW) 430.00p 2.38%
National Express Group (NEX) 324.00p 2.02%
Crest Nicholson Holdings (CRST) 415.80p 2.01%
Fidelity China Special Situations (FCSS) 438.00p 1.86%
Mitchells & Butlers (MAB) 310.80p 1.83%
Restaurant Group (RTN) 124.80p 1.79%
Vistry Group (VTY) 1,232.00p 1.73%
XP Power Ltd. (DI) (XPP) 5,230.00p 1.55%

FTSE 250 - Fallers

Workspace Group (WKP) 801.50p -4.13%
AO World (AO.) 285.80p -3.18%
AJ Bell (AJB) 437.00p -2.85%
Capita (CPI) 42.73p -2.67%
easyJet (EZJ) 984.80p -2.64%
Beazley (BEZ) 328.30p -2.55%
Carnival (CCL) 1,637.20p -2.28%
CMC Markets (CMCX) 491.00p -2.00%
IWG (IWG) 349.90p -1.85%
Allianz Technology Trust (ATT) 2,940.00p -1.84%
More News
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.